Unresectable Dedifferentiated Liposarcoma Clinical Trials

6 clinical trials for Unresectable Dedifferentiated Liposarcoma across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas — RECRUITING · PHASE3
• Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma — RECRUITING · PHASE1
• A Study of Mirdametinib in Combination With Palbociclib in People With Liposarcoma — RECRUITING · PHASE1
• Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma — ACTIVE_NOT_RECRUITING · PHASE2
• Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery — COMPLETED · PHASE2

Refine this search